LAS VEGAS, Nov. 29 /PRNewswire-FirstCall/ -- VMT Scientific Inc. (OTC:VMTF) is excited to announce due to considerable outpouring of interest from diabetics, as well as doctors, its server has been flooded with emails of interest that have been inspiring to say the least. VMT plans to follow up with all contacts that have indicated an interest in getting involved with the company. Providing hope and working towards bringing the VasCir(TM) to the public is why VMT is striving to achieve its objectives. VMT encourages everyone to view its webpage at http://www.vmtf.org/ which will be back up soon. This Press Release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should not place undue reliance on these forward-looking statements. These statements involve risks and uncertainties that could cause actual results to differ materially from those suggested in the forward-looking statements, particularly those risks and uncertainties inherent in the process of developing, manufacturing and distributing medical products and Clinical trials. Factors that may cause such a difference include risks related to VMT Scientific Inc.'s limited operating history, risks associated with completing development and obtaining FDA medical approvals, successful patent protection and prosecution, successful sale of licensed technology nationally or internationally, VMT Scientific technology not meeting with market acceptance, the risk of future warranty and product liability claims, the uncertainty of VMT Scientific Inc.'s future access to capital to sustain operations, achieve profitability or continue as a going concern, the failure by VMT Scientific Inc.'s to secure and maintain relationships with suppliers, manufacturers and other third parties, reliance on key employees, and dependence on intellectual property. These forward-looking statements are based on information and management's expectations as of the date hereof. Future results may differ materially from our current expectations. DATASOURCE: VMT Scientific Inc. CONTACT: Catherine S. Ratelle, Director of Operations of VMT Scientific, Inc., +1-702-990-3477,

Copyright